A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus
نویسندگان
چکیده
Objective To evaluate the usefulness of biomarkers to predict evolution patients suspected systemic lupus erythematosus (SLE), designated as probable SLE (pSLE), into classifiable according American College Rheumatology (ACR) classification criteria. Methods Patients were enrolled by experts if they fulfilled three ACR criteria for and followed approximately 1-3 years transition ACR-classifiable SLE. Individual cell-bound complement activation products (CB-CAPs), serum proteins (C3 C4), autoantibodies measured flow cytometry, turbidimetry, enzyme-linked immunosorbent assay, respectively. Blood levels hydroxychloroquine (HCQ) mass spectrometry. A multianalyte assay panel (MAP), which includes CB-CAPs, was also evaluated. MAP greater than 0.8 reflected optimal cutoff Time fulfillment evaluated Kaplan-Meier analysis Cox proportional hazards model. Results Of 92 with pSLE enrolled, 74 had one or two follow-up visits 9-35 months after enrollment a total 128 visits. Overall, 28 (30.4%) transitioned SLE, including 16 (57%) in first year 12 (43%) afterwards. score at predicted during period (hazard ratio = 2.72; P 0.012), whereas individual Systemic Lupus International Collaborating Clinics did not. HCQ therapy not associated prevention Conclusion Approximately one-third within study period. disease
منابع مشابه
Can Cell Bound Complement Activation Products Predict Inherited Complement Deficiency in Systemic Lupus Erythematosus?
Activation of the classical pathway complement system has long been implicated in stimulating immune complex mediated tissue destruction in systemic lupus erythematosus (SLE). C3 and C4 complement levels are utilized as part of SLE diagnosis and monitoring criteria. Recently, cell bound complement activation products (CBCAPs) have shown increased sensitivity in diagnosing and monitoring lupus a...
متن کاملThe Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus
BACKGROUND Systemic lupus erythematosus (SLE) is a multifaceted disease, and its diagnosis may be challenging. A blood test for the diagnosis of SLE, the Avise Lupus test, has been recently commercialized and validated in clinical studies. OBJECTIVES To evaluate the use of the Avise Lupus test by community rheumatologists. METHODS The study is a longitudinal, case-control, retrospective rev...
متن کاملMeasurements of Cell Bound Complement Activation Products Enhance Diagnostic Performance in Systemic Lupus Erythematosus
متن کامل
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements
OBJECTIVE To compare the performance characteristics of cell-bound complement (C4d) activation products (CBCAPS) on erythrocyte (EC4d) and B cells (BC4d) with antibodies to double-stranded DNA (anti-dsDNA) and complement C3 and C4 in systemic lupus erythematosus (SLE). METHODS The study enrolled 794 subjects consisting of 304 SLE and a control group consisting of 285 patients with other rheum...
متن کاملa comparison of teachers and supervisors, with respect to teacher efficacy and reflection
supervisors play an undeniable role in training teachers, before starting their professional experience by preparing them, at the initial years of their teaching by checking their work within the proper framework, and later on during their teaching by assessing their progress. but surprisingly, exploring their attributes, professional demands, and qualifications has remained a neglected theme i...
15 صفحه اولذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: ACR open rheumatology
سال: 2021
ISSN: ['2578-5745']
DOI: https://doi.org/10.1002/acr2.11219